NCT04565275 2023-03-14
A Study of ICP-192 in Patients With Advanced Solid Tumors
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2 Unknown
Clinical Trials
6 trialsNCT04782804 2022-08-18
Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence
Fudan University
Phase 1/2 Unknown
NCT03943043 2020-07-29
Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer
Istituto Clinico Humanitas
Phase 1/2 Unknown
NCT03042182 2019-08-30
cholangio
Immunitor LLC
Phase 1/2 Unknown
NCT03633773 2018-08-22
Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2 Unknown
NCT02528526 2015-08-19
OXY1A
University of Zurich
Phase 1/2 Unknown